Ardent Health, Inc.
For the period ended Dec 31, 2025. Filed Mar 16, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 16, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ARDENT HEALTH, INC. | |||
| Date: | March 16, 2026 | By: | /s/ Martin J. Bonick |
|---|---|---|---|
| Martin J. Bonick | |||
| President and Chief Executive Officer | |||
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Martin J. Bonick | President and Chief Executive Officer, Director | March 16, 2026 |
| Martin J. Bonick | (Principal Executive Officer) | |
| /s/ Alfred Lumsdaine | Chief Financial Officer | March 16, 2026 |
| Alfred Lumsdaine | (Principal Financial Officer) | |
| /s/ David Byers | Senior Vice President, Chief Accounting Officer | March 16, 2026 |
| David Byers | (Principal Accounting Officer) | |
| /s/ Mark Sotir | Director | March 16, 2026 |
| Mark Sotir | ||
| /s/ Peter Bulgarelli | Director | March 16, 2026 |
| Peter Bulgarelli | ||
| /s/ Peter Bynoe | Director | March 16, 2026 |
| Peter Bynoe | ||
| /s/ Suzanne Campion | Director | March 16, 2026 |
| Suzanne Campion | ||
| /s/ William Goodyear | Director | March 16, 2026 |
| William Goodyear | ||
| /s/ Ellen Havdala | Director | March 16, 2026 |
| Ellen Havdala | ||
| /s/ Edmondo Robinson | Director | March 16, 2026 |
| Edmondo Robinson | ||
| /s/ Rahul Sen | Director | March 16, 2026 |
| Rahul Sen | ||
| /s/ Rob Webb | Director | March 16, 2026 |
| Rob Webb | ||
| /s/ Rob DeMichiei | Director | March 16, 2026 |
| Rob DeMichiei | ||
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| Page | |
| Report of Independent Registered Public Accounting Firm | F-2 |
|---|---|
| Consolidated Financial Statements: | |
| Consolidated Income Statements for the Years Ended December 31, 2025, 2024 and 2023 | F-5 |
| Consolidated Comprehensive Income Statements for the Years Ended December 31, 2025, 2024 and 2023 | F-6 |
| Consolidated Balance Sheets as of December 31, 2025 and 2024 | F-7 |
| Consolidated Statements of Changes in Equity for the Years Ended December 31, 2025, 2024 and 2023 | F-8 |
| Consolidated Statements of Cash Flows for the Years Ended December 31, 2025, 2024 and 2023 | F-9 |
| Notes to Consolidated Financial Statements | F-10 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.